Innoviva

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Innoviva and other ETFs, options, and stocks.

About INVA

Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. 

CEO
Pavel Raifeld
CEOPavel Raifeld
Employees
5
Employees5
Headquarters
Burlingame, California
HeadquartersBurlingame, California
Founded
1996
Founded1996
Employees
5
Employees5

INVA Key Statistics

Market cap
915.56M
Market cap915.56M
Price-Earnings ratio
4.10
Price-Earnings ratio4.10
Dividend yield
Dividend yield
Average volume
577.78K
Average volume577.78K
High today
High today
Low today
Low today
Open price
$12.85
Open price$12.85
Volume
0.00
Volume0.00
52 Week high
$20.71
52 Week high$20.71
52 Week low
$11.57
52 Week low$11.57

INVA Earnings

-$0.01
$0.93
$1.86
$2.80
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 8, After Hours
ActualExpected Feb 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.